ALPELISIB

ALPELISIB was reported 0 times

ALPELISIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PIK3CA RELATED OVERGROWTH SPECTRUM 9 0.5625
1 ACTIVATED PI3 KINASE DELTA SYNDROME 9 0.3913
2 FUNCTIONAL ENDOSCOPIC SINUS SURGERY 9 0.3333
3 PIK3CA-ACTIVATED MUTATION 44 0.1325
4 TUMOUR MARKER DECREASED 23 0.1285
5 CARBOHYDRATE ANTIGEN 15-3 3 0.1000
6 METASTASES TO FALLOPIAN TUBE 3 0.0811
7 LARYNGITIS VIRAL 8 0.0755
8 CALCIFICATION METASTATIC 6 0.0667
9 HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER 22 0.0663
10 MENINGIOMA MALIGNANT 4 0.0656
11 NAIL CUTICLE FISSURE 4 0.0606
12 HYPERGLYCAEMIC CRISIS 3 0.0577
13 FUNGATING WOUND 3 0.0577
14 TUMOUR INFLAMMATION 6 0.0536
15 ROULEAUX FORMATION 3 0.0517
16 PELVIC BONE INJURY 4 0.0460
17 PERITONEAL FLUID ANALYSIS ABNORMAL 4 0.0455
18 HYPERGLYCAEMIA 1520 0.0417
19 PANCREATIC TOXICITY 5 0.0413
20 ORAL MUCOSAL ROUGHENING 3 0.0353
21 ELLIPTOCYTOSIS 3 0.0333
22 TUMOUR MARKER ABNORMAL 11 0.0332
23 METASTASES TO THYROID 3 0.0326
24 APPLICATION SITE INJURY 6 0.0316
25 CARBOHYDRATE ANTIGEN 15-3 INCREASED 21 0.0276
26 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 28 0.0252
27 METASTASES TO NECK 7 0.0251
28 BREAST CANCER METASTATIC 260 0.0242
29 VASCULAR MALFORMATION 5 0.0238
30 METASTASES TO PLEURA 22 0.0210
31 METASTASES TO THORAX 5 0.0198
32 NAEVUS FLAMMEUS 3 0.0192
33 APPLICATION SITE OEDEMA 6 0.0185
34 TUMOUR MARKER INCREASED 83 0.0173
35 POLYMERASE CHAIN REACTION POSITIVE 6 0.0172
36 TUMOUR ULCERATION 4 0.0169
37 SPONTANEOUS BACTERIAL PERITONITIS 4 0.0164
38 CARCINOEMBRYONIC ANTIGEN INCREASED 31 0.0160
39 ADENOID CYSTIC CARCINOMA 2 0.0156
40 METASTASES TO SPINAL CORD 3 0.0155
41 GREATER TROCHANTERIC PAIN SYNDROME 3 0.0146
42 BURN OF INTERNAL ORGANS 2 0.0145
43 METASTASES TO CHEST WALL 5 0.0144
44 DERMAL ABSORPTION IMPAIRED 4 0.0143
45 METASTASES TO PANCREAS 6 0.0135
46 MALIGNANT PERITONEAL NEOPLASM 8 0.0135
47 BREAST DISCOLOURATION 2 0.0126
48 METASTASES TO OVARY 4 0.0125
49 RECTOCELE 7 0.0116
50 METASTASES TO BONE 187 0.0114
51 HORMONE RECEPTOR POSITIVE BREAST CANCER 3 0.0110
52 POIKILOCYTOSIS 3 0.0108
53 BLOOD ALKALINE PHOSPHATASE 2 0.0108
54 SPINAL CORD OEDEMA 4 0.0108
55 METASTASES TO LIVER 181 0.0103
56 INVASIVE BREAST CARCINOMA 4 0.0097
57 POLYDIPSIA 38 0.0096
58 ASPARTATE AMINOTRANSFERASE DECREASED 5 0.0094
59 ANGIOMYOLIPOMA 2 0.0093
60 BONE NEOPLASM 10 0.0093
61 ANISOCYTOSIS 6 0.0091
62 CREATININE RENAL CLEARANCE ABNORMAL 4 0.0086
63 ANION GAP DECREASED 3 0.0086
64 NASAL MUCOSAL DISORDER 5 0.0086
65 INTRA-ABDOMINAL FLUID COLLECTION 15 0.0084
66 GENE MUTATION 16 0.0081
67 METASTASES TO PELVIS 5 0.0079
68 URTICARIAL VASCULITIS 4 0.0076
69 HYPERMETABOLISM 4 0.0075
70 DIABETIC METABOLIC DECOMPENSATION 10 0.0072
71 ORAL MUCOSAL ERUPTION 11 0.0072
72 BACTERIURIA 4 0.0071
73 VULVOVAGINAL INJURY 4 0.0070
74 DIABETIC HYPEROSMOLAR COMA 3 0.0069
75 METASTASES TO SPINE 23 0.0068
76 HILAR LYMPHADENOPATHY 6 0.0068
77 GROWTH RETARDATION 20 0.0068
78 BONE LESION 23 0.0064
79 HEPATIC MASS 12 0.0062
80 TONGUE ERYTHEMA 5 0.0061
81 BLOOD GLUCOSE INCREASED 1137 0.0060
82 SKIN TOXICITY 34 0.0060
83 HEPATIC LESION 26 0.0060
84 ORAL PAIN 132 0.0059
85 METASTASES TO LUNG 68 0.0059
86 KETOACIDOSIS 44 0.0059
87 TASTE DISORDER 119 0.0059
88 APTYALISM 5 0.0059
89 PLEURAL THICKENING 4 0.0058
90 COLONIC ABSCESS 5 0.0058
91 DIABETIC KETOACIDOSIS 140 0.0058
92 BLOOD GLUCOSE ABNORMAL 107 0.0058
93 BLOOD KETONE BODY 2 0.0058
94 NUTRITIONAL CONDITION ABNORMAL 4 0.0057
95 STOMATITIS 345 0.0057
96 PELVIC FLUID COLLECTION 4 0.0057
97 CERVIX DISORDER 4 0.0056
98 ATROPHIC VULVOVAGINITIS 4 0.0055
99 COMA HEPATIC 4 0.0054
100 EOSINOPHIL COUNT ABNORMAL 4 0.0054
101 CREATININE RENAL CLEARANCE INCREASED 4 0.0053
102 VULVOVAGINAL CANDIDIASIS 7 0.0052
103 PSYCHIATRIC DECOMPENSATION 10 0.0051
104 MALIGNANT NEOPLASM PROGRESSION 520 0.0051
105 MUCOSAL DRYNESS 10 0.0050
106 FEEDING DISORDER 100 0.0049
107 PARACENTESIS 3 0.0049
108 DYSBIOSIS 4 0.0049
109 METASTASIS 34 0.0048
110 ALLERGIC SINUSITIS 4 0.0047
111 BLOOD HOMOCYSTEINE INCREASED 2 0.0047
112 GINGIVAL ERYTHEMA 4 0.0046
113 DELIVERY 3 0.0046
114 GINGIVAL DISCOMFORT 3 0.0045
115 BREAST DISORDER 9 0.0044
116 LIP BLISTER 12 0.0044
117 BLOOD OESTROGEN DECREASED 3 0.0043
118 REFLUX GASTRITIS 5 0.0042
119 METASTASES TO LYMPH NODES 28 0.0041
120 EATING DISORDER 87 0.0041
121 THIRST 73 0.0041
122 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 8 0.0040
123 POLYURIA 33 0.0040
124 MUCOSAL DISORDER 4 0.0040
125 VULVOVAGINAL DRYNESS 13 0.0040
126 METASTASES TO PERITONEUM 10 0.0040
127 QRS AXIS ABNORMAL 3 0.0039
128 METASTASES TO SKIN 4 0.0039
129 PRODUCT BLISTER PACKAGING ISSUE 4 0.0038
130 URINE OUTPUT INCREASED 10 0.0038
131 APHTHOUS ULCER 29 0.0037
132 LIP DISORDER 7 0.0037
133 KETONURIA 3 0.0037
134 VERTEBRAL FORAMINAL STENOSIS 3 0.0036
135 BLOOD INSULIN INCREASED 2 0.0036
136 MEAN PLATELET VOLUME DECREASED 3 0.0036
137 TONGUE DISCOMFORT 15 0.0035
138 BREAST CANCER STAGE IV 10 0.0035
139 NONINFECTIVE GINGIVITIS 5 0.0035
140 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 3 0.0034
141 BLOOD OESTROGEN INCREASED 2 0.0034
142 MUCOSAL INFLAMMATION 86 0.0033
143 DIABETES MELLITUS 250 0.0033
144 BLOOD BILIRUBIN DECREASED 2 0.0032
145 ORAL MUCOSAL ERYTHEMA 5 0.0032
146 PRODUCT SUPPLY ISSUE 23 0.0032
147 DIABETIC COMA 9 0.0032
148 RASH 1400 0.0032
149 SOLAR LENTIGO 3 0.0032
150 ORAL DISORDER 23 0.0031
151 ONCOLOGIC COMPLICATION 3 0.0031
152 ANTIBIOTIC THERAPY 3 0.0031
153 LYMPHOEDEMA 21 0.0030
154 PHARYNGEAL ULCERATION 4 0.0030
155 LIP EXFOLIATION 4 0.0030
156 FOOD AVERSION 5 0.0029
157 DISCHARGE 4 0.0029
158 INSULIN RESISTANCE 6 0.0029
159 HAEMATOLOGICAL INFECTION 7 0.0029
160 METASTASES TO CENTRAL NERVOUS SYSTEM 36 0.0028
161 JAW FRACTURE 6 0.0028
162 BLOOD BILIRUBIN UNCONJUGATED INCREASED 2 0.0028
163 FAECES SOFT 20 0.0027
164 DYSENTERY 5 0.0027
165 ADENOCARCINOMA 6 0.0027
166 SECOND PRIMARY MALIGNANCY 22 0.0026
167 MOUTH INJURY 4 0.0026
168 DRY MOUTH 214 0.0026
169 BREAST SWELLING 7 0.0026
170 ASPIRATION PLEURAL CAVITY 2 0.0026
171 ALLERGIC COUGH 2 0.0026
172 MOUTH SWELLING 15 0.0026
173 POLYDACTYLY 3 0.0026
174 VASCULAR RUPTURE 4 0.0026
175 OSTEOSCLEROSIS 4 0.0025
176 BONE CANCER 11 0.0025
177 NEOPLASM 29 0.0025
178 HEPATITIS B REACTIVATION 8 0.0025
179 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 3 0.0025
180 BLOOD ELECTROLYTES ABNORMAL 3 0.0024
181 MEAN CELL HAEMOGLOBIN INCREASED 4 0.0024
182 RED CELL DISTRIBUTION WIDTH INCREASED 10 0.0024
183 CHEILITIS 13 0.0024
184 VEIN RUPTURE 4 0.0024
185 SPINAL DEFORMITY 4 0.0024
186 DECREASED APPETITE 552 0.0024
187 MALIGNANT PLEURAL EFFUSION 4 0.0024
188 GLUCOSE URINE PRESENT 3 0.0024
189 CANCER PAIN 6 0.0023
190 BLOOD BILIRUBIN ABNORMAL 3 0.0023
191 THERAPY CHANGE 23 0.0023
192 BILIARY OBSTRUCTION 3 0.0023
193 PRODUCT PACKAGING DIFFICULT TO OPEN 6 0.0023
194 ACQUIRED GENE MUTATION 3 0.0023
195 BLOOD GLUCOSE FLUCTUATION 25 0.0023
196 GINGIVAL PAIN 18 0.0023
197 TONGUE BLISTERING 5 0.0022
198 PNEUMONITIS 61 0.0022
199 INVASIVE DUCTAL BREAST CARCINOMA 6 0.0022
200 METASTASES TO MENINGES 5 0.0022
201 GLYCOSYLATED HAEMOGLOBIN INCREASED 55 0.0022
202 HEPATIC NEOPLASM 7 0.0021
203 PRERENAL FAILURE 3 0.0021
204 DIARRHOEA 1366 0.0021
205 TUMOUR HAEMORRHAGE 6 0.0021
206 LYMPHADENOPATHY MEDIASTINAL 4 0.0021
207 METASTATIC NEOPLASM 9 0.0021
208 NEOPLASM RECURRENCE 7 0.0021
209 DISEASE PROGRESSION 239 0.0020
210 IRON DEFICIENCY 9 0.0020
211 OSTEONECROSIS OF JAW 49 0.0020
212 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
213 BREAST ABSCESS 2 0.0020
214 PHARYNGEAL SWELLING 19 0.0019
215 BREAST DISCOMFORT 2 0.0019
216 DECREASED IMMUNE RESPONSIVENESS 19 0.0019
217 HOSPICE CARE 19 0.0019
218 LUNG ABSCESS 4 0.0019
219 URINE KETONE BODY PRESENT 3 0.0019
220 WEIGHT DECREASED 530 0.0019
221 ONYCHOCLASIS 13 0.0019
222 DRY THROAT 19 0.0019
223 SKULL FRACTURE 3 0.0018
224 HORMONE LEVEL ABNORMAL 9 0.0018
225 AGEUSIA 46 0.0018
226 RHINALGIA 5 0.0018
227 NEAR DEATH EXPERIENCE 6 0.0018
228 CONCOMITANT DISEASE AGGRAVATED 11 0.0018
229 SKIN REACTION 25 0.0018
230 GASTRIC POLYPS 4 0.0018
231 OESOPHAGEAL STENOSIS 5 0.0018
232 ORAL PRURITUS 4 0.0017
233 LIP PAIN 5 0.0017
234 PAROSMIA 13 0.0017
235 VASCULAR PSEUDOANEURYSM 3 0.0017
236 LIP SWELLING 57 0.0017
237 GLUCOSE TOLERANCE IMPAIRED 10 0.0017
238 COLITIS 63 0.0017
239 MONOPARESIS 3 0.0017
240 RETCHING 35 0.0016
241 BREATH ODOUR 4 0.0016
242 ESSENTIAL HYPERTENSION 3 0.0016
243 NEOPLASM PROGRESSION 57 0.0016
244 PRODUCT DISTRIBUTION ISSUE 15 0.0016
245 BLOOD CREATININE INCREASED 105 0.0016
246 IMPATIENCE 3 0.0016
247 DRUG TOLERANCE 8 0.0016
248 BRAIN NEOPLASM MALIGNANT 7 0.0016
249 MEAN CELL VOLUME INCREASED 4 0.0016
250 BLOOD CHLORIDE DECREASED 4 0.0015
251 ELECTROLYTE IMBALANCE 18 0.0015
252 RASH MACULO-PAPULAR 34 0.0015
253 LUNG OPACITY 4 0.0015
254 APPETITE DISORDER 10 0.0015
255 RENAL FUNCTION TEST ABNORMAL 7 0.0015
256 HYPERPHAGIA 6 0.0015
257 NASAL DISORDER 4 0.0015
258 PRODUCT AVAILABILITY ISSUE 34 0.0015
259 SENSITIVE SKIN 11 0.0015
260 DRUG INTOLERANCE 144 0.0015
261 SENSORY LOSS 12 0.0015
262 TONGUE ULCERATION 5 0.0015
263 DEHYDRATION 197 0.0015
264 APPLICATION SITE DISCOLOURATION 6 0.0015
265 MOUTH ULCERATION 31 0.0015
266 IMMUNE-MEDIATED HEPATITIS 3 0.0015
267 ABNORMAL FAECES 12 0.0015
268 ASCITES 43 0.0015
269 POLYCYTHAEMIA 3 0.0015
270 LIVER FUNCTION TEST INCREASED 31 0.0014
271 BREAST CANCER 133 0.0014
272 BLOOD ELECTROLYTES DECREASED 2 0.0014
273 BREAST PAIN 15 0.0014
274 ILLNESS 143 0.0014
275 PERIODONTITIS 3 0.0014
276 DIVERTICULUM INTESTINAL 6 0.0014
277 LIMB MASS 3 0.0014
278 NEGATIVE THOUGHTS 4 0.0014
279 WOUND 38 0.0014
280 BLOOD CREATINE INCREASED 6 0.0014
281 SPINAL COLUMN INJURY 3 0.0013
282 BACTERIAL TEST POSITIVE 3 0.0013
283 GLOSSODYNIA 30 0.0013
284 OROPHARYNGEAL DISCOMFORT 12 0.0013
285 HYPOGLYCAEMIA 64 0.0013
286 CENTRAL NERVOUS SYSTEM LESION 18 0.0013
287 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 5 0.0013
288 DENGUE FEVER 3 0.0013
289 NODULE 17 0.0013
290 HAIR GROWTH ABNORMAL 9 0.0013
291 HAEMANGIOMA 3 0.0013
292 BILIRUBIN CONJUGATED INCREASED 3 0.0013
293 PLEURAL EFFUSION 78 0.0013
294 POISONING 16 0.0013
295 NAIL DISCOLOURATION 5 0.0013
296 INGROWING NAIL 3 0.0013
297 EOSINOPHIL COUNT DECREASED 3 0.0013
298 FREQUENT BOWEL MOVEMENTS 34 0.0013
299 HYPOVOLAEMIC SHOCK 6 0.0013
300 VITAMIN B12 DEFICIENCY 5 0.0012
301 RASH MACULAR 43 0.0012
302 BODY TEMPERATURE INCREASED 25 0.0012
303 ORAL DISCOMFORT 17 0.0012
304 SKIN ATROPHY 7 0.0012
305 ARTHROPOD STING 2 0.0012
306 RASH PRURITIC 65 0.0012
307 BREAST MASS 8 0.0012
308 BLOOD SODIUM DECREASED 22 0.0012
309 BLOOD CHLORIDE INCREASED 2 0.0012
310 BLOOD CREATININE ABNORMAL 4 0.0012
311 ALOPECIA 227 0.0012
312 TONGUE DISCOLOURATION 5 0.0011
313 BREAST DISCHARGE 2 0.0011
314 ERYTHEMA NODOSUM 4 0.0011
315 PIGMENTATION DISORDER 7 0.0011
316 THERMAL BURN 8 0.0011
317 BLOOD POTASSIUM ABNORMAL 3 0.0011
318 HEPATOTOXICITY 25 0.0011
319 SKIN WEEPING 4 0.0011
320 ANAL INCONTINENCE 10 0.0011
321 FATIGUE 858 0.0011
322 LIP DRY 10 0.0011
323 BLOOD PHOSPHORUS INCREASED 3 0.0011
324 NAUSEA 867 0.0011
325 FOOD INTOLERANCE 4 0.0011
326 PROCTALGIA 7 0.0011
327 RED BLOOD CELL COUNT INCREASED 3 0.0011
328 RASH MORBILLIFORM 3 0.0011
329 STEVENS-JOHNSON SYNDROME 24 0.0011
330 POLLAKIURIA 45 0.0011
331 TRICHORRHEXIS 3 0.0011
332 HEAD DISCOMFORT 19 0.0011
333 ELECTRIC SHOCK SENSATION 3 0.0011
334 PERFORMANCE STATUS DECREASED 5 0.0011
335 POLYP 7 0.0011
336 CANDIDA INFECTION 18 0.0011
337 SKIN TIGHTNESS 5 0.0011
338 PERIORBITAL SWELLING 6 0.0011
339 DEATH 908 0.0011
340 FACE INJURY 4 0.0011
341 VOMITING 495 0.0011
342 BOWEL MOVEMENT IRREGULARITY 8 0.0010
343 CLAVICLE FRACTURE 4 0.0010
344 LIPASE INCREASED 8 0.0010
345 DYSPHAGIA 99 0.0010
346 LUNG CANCER METASTATIC 3 0.0010
347 GASTROINTESTINAL TOXICITY 5 0.0010
348 GINGIVAL DISORDER 4 0.0010
349 TYPE 2 DIABETES MELLITUS 35 0.0010
350 FAECES HARD 4 0.0010
351 DIABETES MELLITUS INADEQUATE CONTROL 18 0.0010
352 ENERGY INCREASED 6 0.0010
353 THERAPY CESSATION 52 0.0010
354 PLEURISY 6 0.0010
355 PULMONARY MASS 15 0.0010
356 NEOPLASM MALIGNANT 67 0.0010
357 HEPATIC ENZYME ABNORMAL 5 0.0010
358 SWELLING FACE 65 0.0010
359 TYPE 1 DIABETES MELLITUS 6 0.0010
360 TOXIC SKIN ERUPTION 10 0.0010
361 ORGAN FAILURE 4 0.0010
362 RHINITIS 8 0.0010
363 THROMBOPHLEBITIS SUPERFICIAL 3 0.0010
364 EMERGENCY CARE 3 0.0010
365 DRY SKIN 132 0.0010
366 QUALITY OF LIFE DECREASED 13 0.0010
367 TRISMUS 5 0.0010
368 MENSTRUAL DISORDER 8 0.0010
369 THERAPY INTERRUPTED 69 0.0010
370 THERAPY PARTIAL RESPONDER 15 0.0010
371 BODY TEMPERATURE FLUCTUATION 2 0.0010
372 TENDERNESS 10 0.0010
373 BLOOD CREATININE DECREASED 3 0.0010
374 BREAST CANCER RECURRENT 3 0.0009
375 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
376 ORTHOPNOEA 3 0.0009
377 ASTHENIA 352 0.0009
378 BLOOD POTASSIUM DECREASED 28 0.0009
379 EAR PAIN 18 0.0009
380 PYELONEPHRITIS 8 0.0009
381 POSTURE ABNORMAL 3 0.0009
382 CHAPPED LIPS 4 0.0009
383 SKIN FISSURES 18 0.0009
384 HYPERTHERMIA 7 0.0009
385 BLOOD GLUCOSE DECREASED 44 0.0009
386 ADVERSE REACTION 12 0.0009
387 RHINITIS ALLERGIC 4 0.0009
388 HAIR TEXTURE ABNORMAL 12 0.0009
389 FACE OEDEMA 15 0.0009
390 SKIN EXFOLIATION 75 0.0009
391 BLOOD BILIRUBIN INCREASED 24 0.0009
392 DYSGEUSIA 66 0.0009
393 URINE ABNORMALITY 4 0.0009
394 NEUTROPHIL COUNT INCREASED 9 0.0009
395 HAEMOGLOBIN INCREASED 4 0.0009
396 HYPERBILIRUBINAEMIA 9 0.0009
397 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
398 LYMPHADENOPATHY 30 0.0008
399 HYPERSENSITIVITY 157 0.0008
400 GLOSSITIS 3 0.0008
401 COLITIS MICROSCOPIC 4 0.0008
402 RENAL DISORDER 39 0.0008
403 BLISTER 47 0.0008
404 SWOLLEN TONGUE 26 0.0008
405 RASH VESICULAR 4 0.0008
406 PRODUCT USE COMPLAINT 13 0.0008
407 ABDOMINAL DISCOMFORT 138 0.0008
408 UTERINE LEIOMYOMA 6 0.0008
409 CEREBRAL DISORDER 6 0.0008
410 TRANSAMINASES INCREASED 18 0.0008
411 PYREXIA 280 0.0008
412 MUCOUS STOOLS 4 0.0008
413 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
414 MALNUTRITION 9 0.0008
415 BONE PAIN 47 0.0008
416 HYDRONEPHROSIS 6 0.0008
417 SWELLING OF EYELID 5 0.0008
418 PHLEBITIS 4 0.0008
419 FEMORAL NECK FRACTURE 4 0.0008
420 MUSCULOSKELETAL CHEST PAIN 12 0.0008
421 RENAL IMPAIRMENT 65 0.0008
422 HYPOALBUMINAEMIA 6 0.0008
423 ORAL INFECTION 3 0.0008
424 FEELING COLD 21 0.0008
425 ANIMAL BITE 2 0.0007
426 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
427 MENINGITIS 5 0.0007
428 TERMINAL STATE 5 0.0007
429 PRURITUS 286 0.0007
430 POOR QUALITY SLEEP 16 0.0007
431 BEHAVIOUR DISORDER 4 0.0007
432 UVEITIS 10 0.0007
433 DECUBITUS ULCER 6 0.0007
434 RECURRENT CANCER 3 0.0007
435 PERIPHERAL ISCHAEMIA 3 0.0007
436 RASH ERYTHEMATOUS 35 0.0007
437 GENERALISED OEDEMA 9 0.0007
438 GENERAL PHYSICAL HEALTH DETERIORATION 84 0.0007
439 DYSPEPSIA 71 0.0007
440 MASS 10 0.0007
441 INTESTINAL PERFORATION 8 0.0007
442 MUSCLE ATROPHY 9 0.0007
443 PAPULE 5 0.0007
444 REBOUND EFFECT 8 0.0007
445 LETHARGY 40 0.0007
446 BLOOD MAGNESIUM DECREASED 6 0.0007
447 SKIN LESION 19 0.0007
448 MADAROSIS 8 0.0007
449 METABOLIC DISORDER 4 0.0007
450 BLOOD PARATHYROID HORMONE INCREASED 2 0.0007
451 NAIL DISORDER 6 0.0007
452 HYPERCHLORHYDRIA 4 0.0007
453 SKELETAL INJURY 7 0.0007
454 CELLULITIS 34 0.0007
455 COVID-19 118 0.0007
456 ODYNOPHAGIA 4 0.0007
457 OEDEMA 36 0.0007
458 URTICARIA 111 0.0007
459 SKIN DISORDER 22 0.0007
460 BLOOD UREA INCREASED 11 0.0007
461 ADVERSE DRUG REACTION 59 0.0007
462 DISEASE COMPLICATION 3 0.0007
463 LIVER DISORDER 29 0.0007
464 BRAIN NEOPLASM 6 0.0007
465 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
466 HYPOKALAEMIA 30 0.0006
467 GASTRITIS 17 0.0006
468 SCOLIOSIS 4 0.0006
469 YELLOW SKIN 3 0.0006
470 SECRETION DISCHARGE 8 0.0006
471 NASAL DRYNESS 4 0.0006
472 GASTROINTESTINAL PAIN 7 0.0006
473 DERMATITIS ALLERGIC 8 0.0006
474 FLATULENCE 36 0.0006
475 SKIN ABRASION 3 0.0006
476 NEUTROPENIA 86 0.0006
477 HEPATIC FAILURE 19 0.0006
478 EYE INFLAMMATION 6 0.0006
479 FRUSTRATION TOLERANCE DECREASED 5 0.0006
480 POST PROCEDURAL INFECTION 5 0.0006
481 PERIPHERAL SWELLING 94 0.0006
482 SKIN DISCOLOURATION 28 0.0006
483 ESCHERICHIA INFECTION 5 0.0006
484 ORAL CANDIDIASIS 8 0.0006
485 TOOTH INFECTION 8 0.0006
486 CHILLS 71 0.0006
487 BLOOD PRESSURE ABNORMAL 12 0.0006
488 MUSCLE INJURY 5 0.0006
489 ABDOMINAL PAIN UPPER 124 0.0006
490 EOSINOPHIL COUNT INCREASED 5 0.0006
491 FLUID INTAKE REDUCED 3 0.0006
492 VEIN DISORDER 3 0.0006
493 SKIN MASS 4 0.0006
494 SWELLING 56 0.0006
495 SPINAL PAIN 7 0.0006
496 ANAPHYLACTIC REACTION 33 0.0006
497 ERYSIPELAS 3 0.0006
498 HYPERSOMNIA 17 0.0006
499 HYPOTHERMIA 6 0.0006
500 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
501 B-CELL LYMPHOMA 2 0.0006
502 NEUROPATHY PERIPHERAL 56 0.0006
503 HYPOPHAGIA 15 0.0006
504 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
505 CACHEXIA 3 0.0006
506 LIMB DISCOMFORT 18 0.0006
507 INFLAMMATION 30 0.0006
508 PULMONARY OEDEMA 26 0.0006
509 SKIN ULCER 15 0.0006
510 HYPERTRANSAMINASAEMIA 4 0.0006
511 LIVER INJURY 14 0.0006
512 SCRATCH 6 0.0006
513 TUMOUR LYSIS SYNDROME 5 0.0006
514 HYPERCALCAEMIA 7 0.0006
515 IMMUNOSUPPRESSION 5 0.0006
516 LUNG INFILTRATION 5 0.0006
517 EYE SWELLING 21 0.0006
518 HAEMORRHOIDS 11 0.0006
519 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
520 SINUS TACHYCARDIA 8 0.0006
521 VISION BLURRED 77 0.0006
522 MOVEMENT DISORDER 18 0.0006
523 FOOD POISONING 3 0.0006
524 FAECES DISCOLOURED 12 0.0006
525 HYDROCEPHALUS 3 0.0006
526 OESOPHAGITIS 6 0.0005
527 NONSPECIFIC REACTION 3 0.0005
528 MOUTH HAEMORRHAGE 4 0.0005
529 DRUG RESISTANCE 14 0.0005
530 RETINAL DETACHMENT 5 0.0005
531 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
532 AMYLASE INCREASED 2 0.0005
533 HIATUS HERNIA 7 0.0005
534 STREPTOCOCCAL INFECTION 3 0.0005
535 NECROSIS 3 0.0005
536 INTERMENSTRUAL BLEEDING 3 0.0005
537 APPENDICITIS 5 0.0005
538 BLOOD CALCIUM DECREASED 6 0.0005
539 URINARY TRACT INFECTION 91 0.0005
540 FRACTURE 10 0.0005
541 PRODUCT PACKAGING ISSUE 5 0.0005
542 MICTURITION URGENCY 6 0.0005
543 MALAISE 230 0.0005
544 ACIDOSIS 4 0.0005
545 DRY EYE 26 0.0005
546 CONSTIPATION 113 0.0005
547 ATELECTASIS 5 0.0005
548 ERYTHEMA 106 0.0005
549 HYPOVOLAEMIA 3 0.0005
550 GASTROINTESTINAL INFLAMMATION 4 0.0005
551 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
552 HEPATOMEGALY 5 0.0005
553 BRADYKINESIA 3 0.0005
554 ABDOMINAL DISTENSION 53 0.0005
555 NASAL DISCOMFORT 4 0.0005
556 BLOOD ALBUMIN DECREASED 4 0.0005
557 APHONIA 7 0.0005
558 SYMPTOM RECURRENCE 3 0.0005
559 AZOTAEMIA 2 0.0005
560 GASTROOESOPHAGEAL REFLUX DISEASE 40 0.0005
561 PLATELET COUNT ABNORMAL 3 0.0005
562 MENTAL IMPAIRMENT 12 0.0005
563 DERMATITIS ACNEIFORM 3 0.0005
564 RASH PAPULAR 11 0.0005
565 ASPARTATE AMINOTRANSFERASE INCREASED 26 0.0005
566 ALANINE AMINOTRANSFERASE INCREASED 30 0.0005
567 FEELING ABNORMAL 117 0.0005
568 HICCUPS 4 0.0005
569 IMPAIRED HEALING 16 0.0005
570 MYELODYSPLASTIC SYNDROME 7 0.0005
571 JAUNDICE 13 0.0005
572 ILEUS 6 0.0005
573 COAGULOPATHY 8 0.0005
574 GASTROINTESTINAL DISORDER 43 0.0005
575 PETECHIAE 5 0.0005
576 HEPATIC CIRRHOSIS 9 0.0005
577 GAIT INABILITY 16 0.0005
578 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
579 SKIN PLAQUE 4 0.0005
580 CYSTITIS 15 0.0005
581 FACIAL PARALYSIS 4 0.0005
582 ABDOMINAL PAIN 109 0.0005
583 THERAPY NON-RESPONDER 21 0.0005
584 OROPHARYNGEAL PAIN 43 0.0005
585 INCOHERENT 3 0.0005
586 HYPONATRAEMIA 26 0.0005
587 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
588 PRODUCT DISPENSING ERROR 10 0.0005
589 KIDNEY INFECTION 9 0.0005
590 LOCALISED INFECTION 11 0.0005
591 LYMPHOCYTE COUNT DECREASED 8 0.0005
592 NEURALGIA 11 0.0005
593 FLUID RETENTION 23 0.0005
594 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
595 HEAVY MENSTRUAL BLEEDING 4 0.0004
596 ILL-DEFINED DISORDER 27 0.0004
597 ULCER 7 0.0004
598 LEUKOPENIA 22 0.0004
599 SCAB 5 0.0004
600 PANCREATITIS 23 0.0004
601 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
602 DYSURIA 16 0.0004
603 PNEUMONIA 140 0.0004
604 BLOOD POTASSIUM INCREASED 7 0.0004
605 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
606 RED BLOOD CELL COUNT DECREASED 12 0.0004
607 HYPERLIPIDAEMIA 5 0.0004
608 PAIN 257 0.0004
609 PRODUCT DOSE OMISSION ISSUE 123 0.0004
610 DEPRESSED MOOD 22 0.0004
611 PARAESTHESIA ORAL 6 0.0004
612 TONGUE DISORDER 3 0.0004
613 BREAST CANCER FEMALE 11 0.0004
614 ORAL HERPES 8 0.0004
615 SEIZURE 47 0.0004
616 PSYCHIATRIC SYMPTOM 3 0.0004
617 HYPOPHOSPHATAEMIA 3 0.0004
618 LIMB INJURY 11 0.0004
619 BACK PAIN 94 0.0004
620 CYST 5 0.0004
621 ABDOMINAL TENDERNESS 2 0.0004
622 OEDEMA PERIPHERAL 49 0.0004
623 NERVOUSNESS 21 0.0004
624 SPEECH DISORDER 21 0.0004
625 EOSINOPHILIA 7 0.0004
626 MUSCLE SPASMS 73 0.0004
627 BRAIN OEDEMA 5 0.0004
628 PRODUCT ADMINISTRATION ERROR 8 0.0004
629 EYE DISORDER 13 0.0004
630 INFECTION 57 0.0004
631 THROMBOCYTOPENIA 44 0.0004
632 PERICARDIAL EFFUSION 9 0.0004
633 CONCUSSION 3 0.0004
634 INTENTIONAL DOSE OMISSION 11 0.0004
635 PELVIC PAIN 7 0.0004
636 CRYING 14 0.0004
637 VENTRICULAR EXTRASYSTOLES 4 0.0004
638 RESPIRATORY FAILURE 28 0.0004
639 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
640 DERMATITIS 8 0.0004
641 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
642 SARS-COV-2 TEST POSITIVE 5 0.0004
643 INCONTINENCE 4 0.0004
644 LIVER FUNCTION TEST ABNORMAL 11 0.0004
645 HEPATIC STEATOSIS 7 0.0004
646 SENSORY DISTURBANCE 6 0.0004
647 UTERINE CANCER 3 0.0004
648 VISUAL IMPAIRMENT 46 0.0004
649 THROAT TIGHTNESS 10 0.0004
650 WHITE BLOOD CELL COUNT DECREASED 40 0.0004
651 INCREASED APPETITE 7 0.0004
652 ASPIRATION 4 0.0004
653 LOWER LIMB FRACTURE 7 0.0004
654 DYSPNOEA 204 0.0004
655 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
656 ACUTE KIDNEY INJURY 55 0.0004
657 HYPOMAGNESAEMIA 5 0.0004
658 HOSPITALISATION 55 0.0004
659 NEPHROPATHY TOXIC 4 0.0004
660 OCULAR DISCOMFORT 4 0.0004
661 SENSATION OF FOREIGN BODY 3 0.0004
662 LYMPHOPENIA 5 0.0004
663 COUGH 99 0.0004
664 PAIN IN JAW 10 0.0004
665 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
666 PARALYSIS 5 0.0003
667 HEPATIC FUNCTION ABNORMAL 13 0.0003
668 FEBRILE NEUTROPENIA 23 0.0003
669 RENAL FAILURE 46 0.0003
670 BLOOD URIC ACID INCREASED 2 0.0003
671 ANOSMIA 5 0.0003
672 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 62 0.0003
673 NEUTROPHIL COUNT DECREASED 14 0.0003
674 BLOOD CHOLESTEROL INCREASED 16 0.0003
675 DYSSTASIA 10 0.0003
676 RIB FRACTURE 7 0.0003
677 LABORATORY TEST ABNORMAL 10 0.0003
678 DRUG ERUPTION 6 0.0003
679 HEPATIC ENZYME INCREASED 23 0.0003
680 GALLBLADDER DISORDER 6 0.0003
681 FACIAL PAIN 3 0.0003
682 SKIN BURNING SENSATION 24 0.0003
683 ACCIDENT 4 0.0003
684 PRODUCT USE IN UNAPPROVED INDICATION 83 0.0003
685 GASTROINTESTINAL INFECTION 3 0.0003
686 GAIT DISTURBANCE 64 0.0003
687 PAIN OF SKIN 9 0.0003
688 STAPHYLOCOCCAL INFECTION 11 0.0003
689 HYPOAESTHESIA ORAL 5 0.0003
690 TOOTHACHE 6 0.0003
691 OSTEOMYELITIS 6 0.0003
692 C-REACTIVE PROTEIN INCREASED 12 0.0003
693 BONE DISORDER 6 0.0003
694 CYTOPENIA 4 0.0003
695 UROSEPSIS 3 0.0003
696 IRON DEFICIENCY ANAEMIA 3 0.0003
697 SMALL INTESTINAL OBSTRUCTION 4 0.0003
698 HEART RATE INCREASED 32 0.0003
699 PHARYNGITIS 4 0.0003
700 THINKING ABNORMAL 6 0.0003
701 HEPATIC ENCEPHALOPATHY 3 0.0003
702 DIARRHOEA HAEMORRHAGIC 3 0.0003
703 PNEUMONIA ASPIRATION 8 0.0003
704 INTESTINAL OBSTRUCTION 12 0.0003
705 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
706 SPINAL DISORDER 3 0.0003
707 ABDOMINAL PAIN LOWER 8 0.0003
708 HEAD INJURY 10 0.0003
709 HAEMATOTOXICITY 3 0.0003
710 PNEUMOTHORAX 5 0.0003
711 HEADACHE 197 0.0003
712 BLOOD PRESSURE INCREASED 48 0.0003
713 METABOLIC ACIDOSIS 10 0.0003
714 PLATELET COUNT DECREASED 33 0.0003
715 CONFUSIONAL STATE 50 0.0003
716 PLATELET COUNT INCREASED 4 0.0003
717 DIZZINESS 153 0.0003
718 LUNG DISORDER 15 0.0003
719 URINARY INCONTINENCE 9 0.0003
720 HYPOTONIA 3 0.0003
721 SPINAL FRACTURE 6 0.0003
722 EYE PRURITUS 10 0.0003
723 DRUG INEFFECTIVE 392 0.0003
724 PERITONITIS BACTERIAL 3 0.0003
725 SUBARACHNOID HAEMORRHAGE 3 0.0003
726 PRODUCT PRESCRIBING ERROR 7 0.0003
727 INSOMNIA 78 0.0003
728 MOBILITY DECREASED 21 0.0003
729 OSTEOPOROSIS 12 0.0003
730 GASTRIC DISORDER 10 0.0003
731 TEMPERATURE INTOLERANCE 3 0.0003
732 DYSPHONIA 17 0.0003
733 EYE DISCHARGE 3 0.0003
734 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
735 BLOOD PRESSURE DECREASED 19 0.0003
736 BLOOD TEST ABNORMAL 4 0.0003
737 HYPOXIA 10 0.0003
738 FULL BLOOD COUNT ABNORMAL 3 0.0003
739 EPISTAXIS 21 0.0003
740 HYPOACUSIS 12 0.0003
741 TOXICITY TO VARIOUS AGENTS 47 0.0003
742 RHINORRHOEA 18 0.0003
743 MEMORY IMPAIRMENT 38 0.0003
744 LEUKOCYTOSIS 5 0.0003
745 SKIN LACERATION 3 0.0003
746 HYPOKINESIA 4 0.0003
747 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
748 APATHY 4 0.0003
749 ANGIOEDEMA 12 0.0003
750 BURNING SENSATION 19 0.0003
751 HAEMATOMA 7 0.0003
752 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
753 NERVE INJURY 3 0.0003
754 URINARY RETENTION 9 0.0003
755 HYPERTENSIVE CRISIS 3 0.0003
756 HYPERTENSION 57 0.0003
757 IMMUNODEFICIENCY 4 0.0003
758 SOMNOLENCE 54 0.0003
759 BACTERIAL INFECTION 5 0.0003
760 ANAEMIA 51 0.0003
761 BREAST TENDERNESS 2 0.0003
762 APHASIA 8 0.0003
763 BLOOD URINE PRESENT 5 0.0003
764 PROTEINURIA 5 0.0003
765 PAIN IN EXTREMITY 77 0.0003
766 SEPSIS 29 0.0003
767 EMOTIONAL DISORDER 8 0.0003
768 HYPOTENSION 52 0.0003
769 FEMUR FRACTURE 8 0.0003
770 DELUSION 4 0.0003
771 MOOD ALTERED 7 0.0003
772 BACTERAEMIA 3 0.0003
773 MENTAL STATUS CHANGES 7 0.0003
774 SYNCOPE 25 0.0002
775 CONTUSION 24 0.0002
776 FULL BLOOD COUNT DECREASED 5 0.0002
777 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
778 DISCOMFORT 15 0.0002
779 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
780 ASPHYXIA 2 0.0002
781 FEELING HOT 15 0.0002
782 HAEMOGLOBIN DECREASED 25 0.0002
783 PARAESTHESIA 38 0.0002
784 HAEMORRHAGE 25 0.0002
785 MYALGIA 40 0.0002
786 PRODUCT USE ISSUE 44 0.0002
787 HYPOAESTHESIA 35 0.0002
788 SEPTIC SHOCK 10 0.0002
789 BLOOD CALCIUM INCREASED 2 0.0002
790 INCORRECT DOSE ADMINISTERED 51 0.0002
791 DRUG-INDUCED LIVER INJURY 7 0.0002
792 SNEEZING 5 0.0002
793 GOUT 4 0.0002
794 GINGIVAL BLEEDING 3 0.0002
795 OFF LABEL USE 190 0.0002
796 MUSCLE TWITCHING 5 0.0002
797 FLUSHING 22 0.0002
798 HUNGER 3 0.0002
799 CHOLELITHIASIS 7 0.0002
800 VERTIGO 13 0.0002
801 DYSPNOEA EXERTIONAL 8 0.0002
802 HOT FLUSH 16 0.0002
803 ACNE 16 0.0002
804 OCULAR HYPERAEMIA 10 0.0002
805 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
806 PULMONARY FIBROSIS 4 0.0002
807 BALANCE DISORDER 18 0.0002
808 HEPATIC CANCER 5 0.0002
809 VAGINAL HAEMORRHAGE 9 0.0002
810 JOINT SWELLING 25 0.0002
811 MENTAL DISORDER 9 0.0002
812 ERUCTATION 4 0.0002
813 WEIGHT INCREASED 46 0.0002
814 TREATMENT FAILURE 17 0.0002
815 AUTOIMMUNE DISORDER 2 0.0002
816 CHEST PAIN 38 0.0002
817 CHOKING 4 0.0002
818 BODY TEMPERATURE DECREASED 2 0.0002
819 LOSS OF CONSCIOUSNESS 26 0.0002
820 HAEMATOCRIT DECREASED 4 0.0002
821 CONDITION AGGRAVATED 61 0.0002
822 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
823 RESPIRATORY DISORDER 6 0.0002
824 BRAIN INJURY 2 0.0002
825 PRODUCT DOSE OMISSION 13 0.0002
826 SUICIDE ATTEMPT 12 0.0002
827 BLOOD COUNT ABNORMAL 3 0.0002
828 HAEMATEMESIS 5 0.0002
829 CARDIOVASCULAR DISORDER 5 0.0002
830 EPILEPSY 6 0.0002
831 TINNITUS 9 0.0002
832 DEVICE RELATED INFECTION 3 0.0002
833 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
834 PRODUCT STORAGE ERROR 17 0.0002
835 ANKLE FRACTURE 3 0.0002
836 TENDONITIS 3 0.0002
837 RASH GENERALISED 5 0.0002
838 DIPLOPIA 5 0.0002
839 ACUTE MYELOID LEUKAEMIA 3 0.0002
840 NERVOUS SYSTEM DISORDER 6 0.0002
841 IRRITABLE BOWEL SYNDROME 4 0.0002
842 RECTAL HAEMORRHAGE 8 0.0002
843 INTERSTITIAL LUNG DISEASE 9 0.0002
844 NASOPHARYNGITIS 34 0.0002
845 SLEEP DISORDER 13 0.0002
846 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
847 TACHYCARDIA 16 0.0002
848 TOOTH DISORDER 4 0.0002
849 COLITIS ULCERATIVE 8 0.0002
850 ARTHRALGIA 74 0.0002
851 FALL 59 0.0002
852 EYE PAIN 10 0.0002
853 CHROMATURIA 4 0.0002
854 CIRCULATORY COLLAPSE 3 0.0002
855 DEPRESSION 40 0.0002
856 SCAR 3 0.0002
857 MUSCULOSKELETAL PAIN 9 0.0002
858 HYPERKALAEMIA 6 0.0002
859 LUNG NEOPLASM MALIGNANT 7 0.0002
860 COLD SWEAT 3 0.0002
861 INFLUENZA LIKE ILLNESS 14 0.0002
862 AMNESIA 11 0.0002
863 COMA 8 0.0002
864 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 34 0.0002
865 IRRITABILITY 10 0.0002
866 ANXIETY 47 0.0002
867 ADRENAL INSUFFICIENCY 2 0.0002
868 AGITATION 12 0.0002
869 ENCEPHALOPATHY 4 0.0002
870 CONJUNCTIVITIS 3 0.0002
871 THROMBOSIS 13 0.0002
872 HYPOCALCAEMIA 3 0.0002
873 GASTRIC ULCER 3 0.0002
874 MOOD SWINGS 5 0.0002
875 HYPOTHYROIDISM 5 0.0002
876 CHOLESTASIS 3 0.0002
877 THROAT IRRITATION 7 0.0002
878 ACUTE RESPIRATORY FAILURE 3 0.0002
879 NIGHT SWEATS 5 0.0002
880 PLASMA CELL MYELOMA 6 0.0002
881 RESPIRATORY TRACT INFECTION 4 0.0002
882 NASAL CONGESTION 9 0.0002
883 DEAFNESS 4 0.0002
884 ECZEMA 8 0.0002
885 UPPER LIMB FRACTURE 3 0.0002
886 EXPIRED PRODUCT ADMINISTERED 5 0.0002
887 COGNITIVE DISORDER 7 0.0001
888 PRODUCT PHYSICAL ISSUE 3 0.0001
889 BRONCHITIS 11 0.0001
890 EXTRA DOSE ADMINISTERED 6 0.0001
891 BLINDNESS 6 0.0001
892 PALLOR 4 0.0001
893 ACUTE HEPATIC FAILURE 2 0.0001
894 HALLUCINATION 11 0.0001
895 PERITONITIS 3 0.0001
896 DELIRIUM 5 0.0001
897 PULMONARY HYPERTENSION 3 0.0001
898 NECK PAIN 8 0.0001
899 DEMENTIA 4 0.0001
900 WITHDRAWAL SYNDROME 6 0.0001
901 INJURY 10 0.0001
902 MUSCULAR WEAKNESS 16 0.0001
903 ANGINA PECTORIS 4 0.0001
904 HERPES ZOSTER 8 0.0001
905 CARDIAC DISORDER 13 0.0001
906 PANIC ATTACK 5 0.0001
907 SURGERY 8 0.0001
908 MIGRAINE 13 0.0001
909 RENAL INJURY 4 0.0001
910 INFLUENZA 15 0.0001
911 PANCREATITIS ACUTE 3 0.0001
912 DYSARTHRIA 5 0.0001
913 HEART RATE IRREGULAR 3 0.0001
914 TREMOR 22 0.0001
915 LACRIMATION INCREASED 4 0.0001
916 ADVERSE EVENT 12 0.0001
917 TREATMENT NONCOMPLIANCE 7 0.0001
918 BRAIN FOG 2 0.0001
919 HAEMATOCHEZIA 7 0.0001
920 PULMONARY EMBOLISM 12 0.0001
921 DISORIENTATION 5 0.0001
922 ARTHROPATHY 7 0.0001
923 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
924 ABSCESS 2 0.0001
925 INJECTION SITE URTICARIA 3 0.0001
926 EYE IRRITATION 7 0.0001
927 SUICIDAL IDEATION 11 0.0001
928 FUNGAL INFECTION 4 0.0001
929 ANGER 4 0.0001
930 CHEST DISCOMFORT 12 0.0001
931 ANAPHYLACTIC SHOCK 3 0.0001
932 UNRESPONSIVE TO STIMULI 3 0.0001
933 EAR INFECTION 3 0.0001
934 MENSTRUATION IRREGULAR 3 0.0001
935 FEAR 3 0.0001
936 DISTURBANCE IN ATTENTION 6 0.0001
937 RESTLESSNESS 4 0.0001
938 ABNORMAL DREAMS 3 0.0001
939 AGRANULOCYTOSIS 2 0.0001
940 PANCYTOPENIA 6 0.0001
941 SINUSITIS 11 0.0001
942 PRODUCTIVE COUGH 5 0.0001
943 NEEDLE ISSUE 3 0.0001
944 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
945 PALPITATIONS 12 0.0001
946 ACUTE MYOCARDIAL INFARCTION 3 0.0001
947 DRUG INTERACTION 16 0.0001
948 CATARACT 6 0.0001
949 CEREBROVASCULAR ACCIDENT 17 0.0001
950 CARDIAC FAILURE 8 0.0001
951 CARDIO-RESPIRATORY ARREST 4 0.0001
952 HIP FRACTURE 3 0.0001
953 HYPERHIDROSIS 12 0.0001
954 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
955 OSTEONECROSIS 3 0.0001
956 VIRAL INFECTION 3 0.0001
957 OXYGEN SATURATION DECREASED 5 0.0001
958 NEPHROLITHIASIS 4 0.0001
959 CARDIAC ARREST 7 0.0001
960 WHEEZING 5 0.0001
961 DISEASE RECURRENCE 4 0.0001
962 CEREBRAL HAEMORRHAGE 3 0.0001
963 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
964 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
965 THERAPEUTIC RESPONSE DECREASED 5 0.0001
966 UNEVALUABLE EVENT 6 0.0001
967 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
968 MYOCARDIAL INFARCTION 13 0.0001
969 ATRIAL FIBRILLATION 7 0.0001
970 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
971 OSTEOARTHRITIS 3 0.0001
972 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
973 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
974 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
975 EXPOSURE DURING PREGNANCY 4 0.0001
976 ARTHRITIS 5 0.0001
977 ARRHYTHMIA 3 0.0001
978 CARDIAC FAILURE CONGESTIVE 5 0.0001
979 AGGRESSION 3 0.0001
980 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
981 BRADYCARDIA 3 0.0001
982 ACCIDENTAL OVERDOSE 2 0.0001
983 DEEP VEIN THROMBOSIS 3 0.0000
984 PSORIASIS 6 0.0000
985 INFUSION RELATED REACTION 3 0.0000
986 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
987 INJECTION SITE PRURITUS 3 0.0000
988 OVERDOSE 9 0.0000
989 CHRONIC KIDNEY DISEASE 3 0.0000
990 INJECTION SITE SWELLING 3 0.0000
991 INJECTION SITE PAIN 12 0.0000
992 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
993 MUSCULOSKELETAL STIFFNESS 3 0.0000
994 EMOTIONAL DISTRESS 3 0.0000